Research Article
Pediatric Sickle Cell Disease in Sudan: Complications and Management
Table 4
Management of patients with sickle cell disease (N = 207).
| | Management | Frequency | Percent |
| | Folic acid | 207 | 100.0 | | Hydroxyurea | 153 | 73.9 | | Supplements | 95 | 45.9 | | Antibiotics for infections | 15 | 7.2 | | Analgesics | 10 | 4.8 | | Prophylactic penicillins (N = 31) | 31 | 15.0 | | Amoxicillin | 27 | 87.1 | | Penicillin VK | 4 | 12.9 | | None | 176 | 85.0 | | Vaccination | | Pneumococcal vaccine | 85 | 41.1 | | None | 122 | 58.9 | | Blood transfusion | | Yes | 144 | 69.6 | | No | 63 | 30.4 |
|
|
